Ligand validation:4EXZ

ACT: ACETATE ION

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4EXZ_ACT_A_201	62%	60%	0.114	0.906	1.15	0.42	-	-	7	0	100%	1
4EXZ_ACT_B_201	47%	39%	0.151	0.889	0.65	1.69	-	1	3	0	100%	1
4RUU_ACT_A_202	88%	39%	0.074	0.95	0.78	1.59	-	1	0	0	100%	1
4ZJ0_ACT_A_201	85%	22%	0.076	0.942	1.17	2.07	-	2	4	0	100%	1
5FFH_ACT_A_201	81%	39%	0.099	0.95	0.76	1.62	-	1	0	0	100%	1
7LSQ_ACT_A_201	75%	43%	0.112	0.945	0.81	1.38	-	-	0	0	100%	1
4ZGU_ACT_A_201	71%	22%	0.123	0.943	0.59	2.6	-	2	1	0	100%	1
5LDS_ACT_C_1011	100%	58%	0.023	0.997	0.82	0.79	-	-	0	0	100%	1
2GH1_ACT_B_302	100%	7%	0.032	0.996	1.81	2.93	1	2	1	0	100%	1
4RS3_ACT_A_434	100%	55%	0.036	0.991	0.69	1.05	-	-	0	0	100%	1
8Q64_ACT_A_703	100%	38%	0.034	0.989	1.18	1.25	-	-	0	0	100%	1
2VB1_ACT_A_201	100%	8%	0.036	0.99	3.47	1.22	2	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.